# High Flux Hemodialysis Thrice Versus Once

> **NCT00714662** · PHASE3 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- End-Stage Renal Disease

## Interventions

- **DEVICE:** high flux hemodialyzer (FX-60, FX-80 or FX-100)

## Key facts

- **NCT ID:** NCT00714662
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2009-02
- **Final completion:** 2009-03
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2008-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00714662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00714662, "High Flux Hemodialysis Thrice Versus Once". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00714662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*